Our Partners

Regulatory Science Institute, Inc. (RSI), based in Kyoto, Japan, provides services on research /survey of regulations and consultancy on drug development to help pharmaceutical companies solve problems, and conduct more scientific and efficient drug development in Japan, as well as in the United States and EU.

MicroConstants China, Inc (MC), based in Beijing, China, is a contract research organization that serves as partner for pharmaceutical development outsourced to China. In addition to planning and conducting phase 1 clinical studies MC provides clinical and preclinical sample bioanalysis, and consulting for market entry into China. MC is one of the few Chinese companies that are compliant to USFDA, OECD, and JMHLW GLP guidelines and conducts quality systems evaluations and training for Chinese companies.